Radiopharmaceuticals Market in Good Shape in 2019; COVID-19 to Affect Future Growth Trajectory

1. Radiopharmaceuticals Market Analysis 2019 – 2029 A recent market study published by Future Market Insights on the radiopharmaceuticals market includes global industry analysis for 2014 – 2018 & opportunity assessment for 2019 – 2029, and delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the radiopharmaceuticals market, the growth prospects of the market are obtained with maximum precision. Report Chapters Chapter 01 – Executive Summary The report initiates with the executive summary of the radiopharmaceuticals market, which includes a summary of key findings and statistics of the market. It also includes drivers and trends pertaining to the radiopharmaceuticals market. Chapter 02 – Market Overview Readers can find the definition and a detailed segmentation of the radiopharmaceuticals market in this chapter, which will help them understand the basic information about the radiopharmaceuticals market. Along with this, comprehensive information pertaining to radiopharmaceuticals and their properties are provided in this section. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the radiopharmaceuticals market report. To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1992 Chapter 03 – Market Dynamics This section gives information about drivers, and restraints of the radiopharmaceuticals market. This section also includes various opportunities and key trends of the radiopharmaceuticals market. Chapter 04 – Market Context This section gives information about upcoming pipeline products, PEST analysis, Porter’s Five Forces Model, and regulatory scenario of the radiopharmaceuticals market. Chapter 05 – Global Radiopharmaceuticals Market Demand Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029

2. This section explains the global market value analysis and forecast for the radiopharmaceuticals market between the forecast periods of 2019 – 2029. This chapter includes a detailed analysis of the historical radiopharmaceuticals market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029). Chapter 06 – Global Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029, by Radioisotope Based on radioisotope, the radiopharmaceuticals market is segmented into Technetium-99, Fluorine-18, Iodine-131, Leutetium-177, Yttrium-90, Gallium- 68, Gallium-67, Rubidium-82, Iodine-123, Iodine-125, Indium-111 and others. In this chapter, readers can find information about the key trends and developments in the radiopharmaceuticals market and market attractiveness analysis based on radioisotope. Chapter 07 – Global Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029, by Application Based on application, the radiopharmaceuticals market is segmented into oncology, cardiology, gastroenterology, neuroendocrinology, neurology, nephrology and others. In this chapter, readers can understand the market attractive analysis based on application. Chapter 08 – Global Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029, by Source Based on application, the radiopharmaceuticals market is segmented into cyclotrons and nuclear reactors. In this chapter, readers can understand the market attractive analysis based on source. Download Methodology of this Report @ https://www.futuremarketinsights.com/askus/rep-gb-1992 Chapter 09 – Global Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029, by End User This chapter provides details about the radiopharmaceuticals market based on the end user, and has been classified into hospitals, diagnostic imaging centers, ambulatory surgical centers and cancer research institutes. In this chapter, readers can understand the market attractive analysis based on end user.

3. Chapter 10 – Global Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029, by Region This chapter explains how the radiopharmaceuticals market will grow across various geographic regions such as North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan, and Middle East & Africa (MEA). Chapter 11 – North America Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029 This chapter includes a detailed analysis of the growth of the North America Radiopharmaceuticals market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on the radioisotope, application, source, end user, and countries in North America. Chapter 12 – Latin America Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029 This chapter provides the growth scenario of the radiopharmaceuticals market in Latin American countries such as Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided. Request for covid19 Impact Analysis @ https://www.futuremarketinsights.com/covid19/rep-gb-1992 Chapter 13 – Western Europe Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029 Important growth prospects of the radiopharmaceuticals market based on its end users in several countries such as the U.K., France, Germany, Spain, Italy, Nordic Countries, Benelux and the Rest of Western Europe are included in this chapter. Chapter 14 – Eastern Europe Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029 Important growth prospects of the radiopharmaceuticals market based on its end users in several countries such as Russia, Poland and the Rest of Eastern Europe are included in this chapter. Chapter 15 – Asia Pacific excluding Japan (APEJ) Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029

4. In this chapter, China, India, Australia and New Zealand, ASEAN and Rest of Asia Pacific countries are the prominent countries in the Asia Pacific excluding Japan region that are the prime subjects of assessment to obtain the growth prospects of the APEJ radiopharmaceuticals market. Readers can find detailed information about the growth parameters of the APEJ radiopharmaceuticals market during the forecast period of 2019 – 2029. Chapter 16 – Japan Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029 This section highlights the growth prospects of the radiopharmaceuticals market for Japan, during the forecast period of 2019 – 2029. Chapter 17 – MEA Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029 This chapter provides information about how the radiopharmaceuticals market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period of 2019 – 2029. Chapter 18 – Competition Analysis In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the radiopharmaceuticals market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are GE Healthcare, Siemens (Siemens Healthineers), Novartis (Advanced Accelerator Applications), Lantheus Holdings, Inc., Eckert & Ziegler, Positron Corporation, Bayer AG, Curium and Sotera Health LLC (Nordion, Inc.). Chapter 19 – Assumptions and Acronyms This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the radiopharmaceuticals market report. Chapter 20 – Research Methodology This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the radiopharmaceuticals market.